Michele Ceccarelli

26PUBLICATIONS
138CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMedical mycologyMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 23, 2026
GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.

|Jun 10, 2026
Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions.

|May 07, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma.

|Apr 27, 2026
Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study.

|Nov 24, 2025
Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy.

Erika Ciervo, Francesco Ceccarelli, Anna Maria Di Giacomo

|Oct 22, 2025
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression.

Mylan R Blomquist, Teresa M R Noviello, Christopher Sereduk

Pageof 5

Frequent Collaborators

6 joint publications

Francesca Pia Caruso

4 joint publications

Fulvio D'Angelo

4 joint publications

Antonio Iavarone

3 joint publications

Teresa Maria Rosaria Noviello